Deliverance Agyabeng

Deliverance is a biotechnology company focused on developing a platform for the intracellular delivery of large-molecule therapeutics, such as proteins and nucleic acids. The company's technology aims to overcome the significant challenge of delivering biologics across cell membranes to reach intracellular targets, which has historically limited the scope of drug development. By enabling the delivery of diverse therapeutic payloads into the cytoplasm and nucleus, Deliverance seeks to unlock new treatment possibilities for a wide range of diseases. The company is currently in the pre-clinical stage, refining its delivery systems to enhance efficacy and safety for future clinical applications.